SCHEMBL3636710

SCHEMBL3636710

COC(=O)c1cccc(C(O)c2ccc(C)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
TCF4 P15884 1/20 0.50
CTNNB1 P35222 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
CA12 O43570 1/20 0.45
CA14 Q9ULX7 1/20 0.45
TSHR P16473 1/20 0.44
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
ALDH1A1 P00352 4/20 0.43
MAPT P10636 3/20 0.43
HPGD P15428 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
GPR17 Q13304 1/20 0.43
SLC7A5 Q01650 1/20 0.43
CASR P41180 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340741 0.89 GPR17 (0.50) TDP1TCF4CTNNB1LOXL2TSHR
SCHEMBL3340488 0.89 TSHR (0.58) LOXL2CA1CA2CA9TSHR
SCHEMBL2458334 0.87 KMT2A (0.46) LOXL2CA1CA2CA9CA12
SCHEMBL4810030 0.85 LOXL2 (0.50) LOXL2CA1CA2CA9CA12
SCHEMBL9149153 0.85 TDP1 (0.51) TDP1LOXL2CA1CA2CA9
SCHEMBL1568650 0.82 ADRB2 (0.54) LOXL2TSHRCYP4F2CYP4A11ALDH1A1
SCHEMBL4407209 0.80 TSHR (0.53) LOXL2CA1CA2CA9CA12
SCHEMBL4407205 0.80 TSHR (0.53) LOXL2CA1CA2CA9CA12
SCHEMBL2650423 0.80 TSHR (0.53) LOXL2CA1CA2CA9CA12
SCHEMBL14108185 0.80 OPRD1 (0.48) TDP1TSHRALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170815-A2 RENIN INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2010-04-07 EP disclosed
WO-2008156817-A2 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2008-12-24 WO disclosed